(Q72935780)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8378189%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

title

Inhibition of growth of experimental prostate cancer in rats by LH-RH analogs linked to cytotoxic radicals (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8378189%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference

2

A V Schally

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8378189%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

author name string

J Pinski

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8378189%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

T Yano

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8378189%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

K Szepeshazi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8378189%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

G Halmos

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8378189%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

K Groot

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8378189%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

A M Comaru-Schally

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8378189%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

S Radulovic

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8378189%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

A Nagy

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8378189%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

publication date

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8378189%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8378189%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8378189%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8378189%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

page(s)

165-178

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8378189%20AND%20SRC:MED&resulttype=core&format=json

Prostate Cancer: continuing progress

30 October 2019

cites work

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990230209

Synthesis of methotrexate-antibody conjugates by regiospecific coupling and assessment of drug and antitumor activities

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990230209

Hormone-drug conjugates.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990230209

The effects of gonadotrophin releasing hormone analogues in prostate cancer are mediated through specific tumour receptors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990230209

Combination of long-acting microcapsules of the D-tryptophan-6 analog of luteinizing hormone-releasing hormone with chemotherapy: investigation in the rat prostate cancer model

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990230209

Estramustine phosphate (Estracyt) in the treatment of prostatic carcinoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990230209

Combination of a long-acting delivery system for luteinizing hormone-releasing hormone agonist with Novantrone chemotherapy: increased efficacy in the rat prostate cancer model.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990230209

Clinical study of leuprolide depot formulation in the treatment of advanced prostate cancer. The Leuprolide Study Group

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990230209

Methotrexate analogues. 14. Synthesis of new gamma-substituted derivatives as dihydrofolate reductase inhibitors and potential anticancer agents

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990230209

Chemotherapy Programs of the National Prostatic Cancer Project (NPCP)

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990230209

Inhibition of growth of experimental prostate cancer with sustained delivery systems (microcapsules and microgranules) of the luteinizing hormone-releasing hormone antagonist SB-75.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990230209

Chemotherapy principles in the treatment of prostatic cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990230209

Receptors for luteinizing hormone-releasing hormone (LHRH) in Dunning R3327 prostate cancers and rat anterior pituitaries after treatment with a sustained delivery system of LHRH antagonist SB-75.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990230209

The presence of LHRH-like receptors in Dunning R3327H prostate tumors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990230209

Highly potent metallopeptide analogues of luteinizing hormone-releasing hormone.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990230209

Histological changes in Dunning prostate tumors and testes of rats treated with LH-RH antagonist SB-75.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990230209

Analogues of luteinizing hormone-releasing hormone containing cytotoxic groups

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990230209

Prolonged inhibition of luteinizing hormone and testosterone levels in male rats with the luteinizing hormone-releasing hormone antagonist SB-75.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990230209

Randomised controlled study of orchidectomy vs long-acting D-Trp-6-LHRH microcapsules in advanced prostatic carcinoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990230209

Gonadotropin releasing hormone binding sites in human epithelial ovarian carcinomata

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990230209

Highly potent analogues of luteinizing hormone-releasing hormone containing D-phenylalanine nitrogen mustard in position 6.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990230209

The importance of prognostic factors in advanced prostate cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990230209

Receptors for luteinizing hormone-releasing hormone, somatostatin, prolactin, and epidermal growth factor in rat and human prostate cancers and in benign prostate hyperplasia

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990230209

2-Methylanthraquinone derivatives as potential bioreductive alkylating agents

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990230209

Effect of luteinizing hormone-releasing hormone analogs containing cytotoxic radicals on growth of estrogen-independent MXT mouse mammary carcinoma in vivo

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990230209

Differential effects of growth factor antagonists on neoplastic and normal prostatic cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990230209

The timing of androgen ablation therapy and/or chemotherapy in the treatment of prostatic cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990230209

Identifiers

DOI

10.1002/PROS.2990230209

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8378189%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference